AN2 Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for the treatment of infectious diseases, particularly those caused by viruses
The company is dedicated to advancing its pipeline of novel antiviral therapies, leveraging cutting-edge research to address urgent medical needs. With a commitment to improving patient outcomes, AN2 employs a science-driven approach to create effective and accessible treatment options, ultimately aiming to contribute to global public health efforts. Through rigorous clinical development and collaboration with healthcare professionals, the company strives to bring transformative solutions to patients suffering from serious infectious diseases.
AN2 Therapeutics reported topline results from the Phase 2/3 EBO-301 study of epetraborole in treatment-refractory MAC lung disease. The study showed similar sputum culture conversion rates between treatment arms, leading to the trial's termination and a 50% workforce reduction.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
U.S. stocks traded mostly higher toward the end of trading, while the Nasdaq Composite moved slightly lower on Monday. The Dow traded up 0.52% to 38,873.28 while the NASDAQ fell 0.10% to 15,975.16. The S&P 500 also rose, gaining, 0.12% to 5,032.46.
Shares of Big Lots, Inc. (NYSEBIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and lowered its price target from $6 to $1.
U.S. stocks traded higher midway through trading, with the Dow Jones index jumping over 150 points on Monday. The Dow traded up 0.48% to 38,856.99 while the NASDAQ rose 0.26% to 16,031.87. The S&P 500 also rose, gaining, 0.30% to 5,041.87.
U.S. stocks traded mixed this morning, with the Dow Jones index falling around 20 points on Monday. Following the market opening Monday, the Dow traded down 0.05% to 38,651.80 while the NASDAQ rose 0.09% to 16,004.39. The S&P 500 also rose, gaining, 0.01% to 5,026.74.
U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 45 points on Monday. Shares of monday.com Ltd. (NASDAQMNDY) fell sharply in today’s pre-market trading after the company reported fourth-quarter financial results.
